All News

Amlexanox may alter genes that improve blood glucose control in patients with type 2 diabetes.

Investigational vaccine inhibits euphoria associated with heroin use.

Tremfya is the first and only approved biologic that selectively blocks the interleukin-23 protein.

A look at last week's top stories in the world of pharmacy.

Tremfya found to achieve significantly clearer skin in moderate to severe plaque psoriasis.

Voluntary medical male circumcision may help to reduce the spread of HIV.

A look at the top stories in pharmacy this week.

Opioids have caused more than 70% of health events among patients with drug use disorder around the world.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Top news of the week from Specialty Pharmacy Times.

Vitamin B12 (cobalamin) is a workhorse vitamin.

Learn about the new products and expanded indications approved by the FDA in June 2017.

Jason Westin, MD, an oncologist running for Congress, discusses the importance of stakeholder input for healthcare reform.​

Patients with obstructive sleep apnea and type 2 diabetes have an increased risk of retinopathy.

Racial and ethnic disparities closely linked to cost and value of care.

CDKL5 Disorder is characterized by seizures and neuro-developmental impairment.

Emicizumab is administered subcutaneously only once per week compared with clotting factors administered intravenously 3 times per week.

Selective oral immunomodulator plus tenofovir alafenamide (Vemlidy) seeks functional cure in chronic HBV.

Bills introduced at the state level would increase provider accountability for controlled substances.

CTL019 is a chimeric antigen receptor T cell therapy.

Women who breastfed for at least 2 years reduced the risk of heart disease by 18% and stroke by 17%.

Patentiflorin A better inhibited viral replication than azidothymidine, which could lead to an HIV cure.

Top news of the day from across the health care landscape.

Increasingly, individuals with HIV also have comorbid conditions, such as cardiovascular disease, hypertension, and diabetes.

Top news of the day from across the healthcare landscape.

Individuals who drink coffee each day found less likely to die compared with non-coffee drinkers from several different health conditions.

The once-daily drug contains bictegravir and emtricitabine/tenofovir to treat adults with HIV-1.

This brand has evolved over the past 2 decades.

Aspirin as we know it today is one of the cheapest and oldest painkillers on the market, but its therapeutic uses have expanded since it's development in the 19th century.